SAA Rapid Quantitative Test
- UID
- IMP/IVD/2022/000074_6b6e0fb0d438481d961ddc5a52b538f8_3d568b6416aed37082618e1274abcfcb
- Device class
- Class B
- Brand name
- Glycated Hemoglobin
- License holder
- FINOVA HEALTHCARE PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- The Serum Amyloid A (Glycated Hemoglobin) Rapid Quantitative Test along with Aehealth Fluorescence Immunoassay Analyzer (Glycated Hemoglobin) is intended for in vitro quantitative determination of SAA in human whole blood, serum or plasma. It is mainly as a non-specific inflammation indicator
SAA Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_6b6e0fb0d438481d961ddc5a52b538f8_3d568b6416aed37082618e1274abcfcb. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.